New model aims to predict lung cancer treatment success and dangerous side effect
NCT ID NCT07243899
First seen Nov 25, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study looked at 3,000 people with advanced non-small cell lung cancer to see if a model using CT scans, lung function tests, and blood markers could predict how well immunotherapy combined with chemotherapy works. It also aimed to predict the risk of a serious side effect called chemotherapy-induced pneumonitis (lung inflammation). The goal is to help doctors personalize treatment and avoid severe complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
180 Fenglin Road
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.